aspirin has been researched along with Experimental Neoplasms in 48 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin has been proposed in recent years as a candidate for chemoprevention of adenocarcinoma in patients with Barrett's esophagus." | 7.80 | Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model. ( Cebrián, C; Esquivias, P; García-González, MA; Lanas, A; Morandeira, A; Ortego, J; Piazuelo, E; Santander, S, 2014) |
| "Luteolin (LUT) has cancer prevention and anti-inflammatory effects." | 5.42 | Luteolin supplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats. ( Ahmed, ES; El-Waseef, AM; Osman, NH; Said, UZ, 2015) |
| " Combination therapy may produce synergic effects with better tumor inhibition as well as lower dosage or side affects." | 5.31 | [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma]. ( Tang, CW; Tang, LP; Wang, CH, 2002) |
| " This study investigated the protective role of ASA in azoxymethane (AOM)-initiated and dextran sulfate sodium (DSS)-promoted colitis-associated colon cancer (CAC) and examined the epigenetic effects, particularly on histone 3 lysine 27 acetylation (H3K27ac), underlying the preventive effect of ASA." | 3.83 | The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice. ( Guo, Y; Huang, MT; Kong, AN; Li, W; Liu, Y; Su, ZY; Zhang, C, 2016) |
| "Aspirin has been proposed in recent years as a candidate for chemoprevention of adenocarcinoma in patients with Barrett's esophagus." | 3.80 | Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model. ( Cebrián, C; Esquivias, P; García-González, MA; Lanas, A; Morandeira, A; Ortego, J; Piazuelo, E; Santander, S, 2014) |
| " In this work, we tested the ability of aspirin to activate the AKT survival pathway in methylcholanthrene-induced fibrosarcoma cells (Meth A) transplanted into BALB/c nude mice and the clinical effect of aspirin cotreatment during etoposide (VP-16)-based anticancer therapy." | 3.73 | Aspirin reduces the outcome of anticancer therapy in Meth A-bearing mice through activation of AKT-glycogen synthase kinase signaling. ( Acquaviva, AM; Acquaviva, F; Di Matola, T; di Palma, A; Leone, V; Matarese, G; Ricchi, P, 2006) |
| "The aim of this study is to assess the role of high fibre diet and aspirin on dimethylhydrazine (DMH)-induced colorectal cancer in rats." | 3.72 | The effect of aspirin and high fibre diet on colorectal carcinoma: a comparative experimental study. ( Kiskinis, D; Miliaras, D; Miliaras, S; Vrettou, E; Zavitsanakis, A, 2004) |
| "The growth rate (studied by mean tumor dry weight) and vascularization (studied by microangiography) of two transplantable rat tumors, a 20-methylcholanthrene-induced fibrosarcoma and a hepatoma, were significantly reduced by three prostaglandin synthesis inhibitors, indomethacin, diclofenac-sodium and aspirin, irrespective of whether the drugs were administered early or late during tumor growth." | 3.66 | Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat. ( Peterson, HI, 1983) |
| " The effects of warfarin, aspirin and heparin administration on the early arrest patterns of 125IdUrd-labelled TA3 carcinoma and Gardner lymphosarcoma cells injected intravenously into tumor-bearing mice were examined." | 3.66 | Initial tumor cell arrest in animals of defined coagulative status. ( Glaves, D; Weiss, L, 1978) |
| "In lay terms "cancers follow bleeding", which seems to be true for antithrombotic agents in general." | 2.52 | Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges. ( Cabrera-Fuentes, HA; Cherepanov, V; Kim, MH; Serebruany, VL, 2015) |
| "UVR promotes skin cancer through multiple mechanisms, including induction of inflammation, oxidative stress, and DNA damage such as 8-oxoguanine and cyclobutane pyrimidine dimers." | 1.62 | Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo. ( Boucher, KM; Burd, CE; Florell, SR; Grossman, D; Kumar, D; Liu, T; Lum, D; Okwundu, N; Rahman, H; VanBrocklin, MW, 2021) |
| " In this work, we reported a novel kind of BiOI@CuS nanoparticle to achieve safe and effective therapy of lung cancer by co-loading hydrochloric acid doxorubicin (DOX) and aspirin phenacetin and caffeine (APC)." | 1.51 | Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer. ( Cheng, J; He, D; Huang, G; Li, W; Wang, R; Zhang, Y; Zhu, J, 2019) |
| "However, postsurgical metastasis poses an immense setback in cancer therapy." | 1.51 | Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection. ( Himmel, LE; Jyotsana, N; King, MR; Yu, F; Zhang, Z, 2019) |
| "1-Pyrene methanol was utilize to synthesize the anti-inflammatory prodrug pyrene-aspirin (P-aspirin) with a cleavable ester bond and also facilitate loading the prodrug on gold nanorod (AuNR)-encapsulated graphitic nanocapsule (AuNR@G), a photothermal agent, through π-π interactions." | 1.48 | Simultaneous Application of Photothermal Therapy and an Anti-inflammatory Prodrug using Pyrene-Aspirin-Loaded Gold Nanorod Graphitic Nanocapsules. ( Chen, L; Chen, Z; Dong, Q; Hu, X; Song, L; Tan, W; Wang, X; Xiao, L; Xu, M; Zhang, L; Zou, Y, 2018) |
| " The two NSAIDs proved to be safe and efficacious in the experimental model used." | 1.43 | Selective inhibition by aspirin and naproxen of mainstream cigarette smoke-induced genotoxicity and lung tumors in female mice. ( Balansky, R; D'Oria, C; De Flora, S; Ganchev, G; Iltcheva, M; La Maestra, S; Micale, RT; Steele, VE, 2016) |
| "Luteolin (LUT) has cancer prevention and anti-inflammatory effects." | 1.42 | Luteolin supplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats. ( Ahmed, ES; El-Waseef, AM; Osman, NH; Said, UZ, 2015) |
| "NOSH-aspirin is a potent anti-inflammatory, preferentially affecting cancer cells and targets parameters important in determining cellular mass." | 1.42 | Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer Agents. ( Kashfi, K, 2015) |
| " We investigated the long-term administration of low dose of aspirin in a model of experimental colon carcinogenesis in rats." | 1.36 | Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis. ( Bouhadjar, M; Bousserouel, S; Gosse, F; Marescaux, J; Raul, F; Soler, L, 2010) |
| " Combination therapy may produce synergic effects with better tumor inhibition as well as lower dosage or side affects." | 1.31 | [Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma]. ( Tang, CW; Tang, LP; Wang, CH, 2002) |
| "Pulmonary metastases with CT26 cells could be inhibited by induction of thrombocytopenia, and reconstituted by infusion of either murine or human platelets." | 1.27 | Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. ( Ambrogio, C; Coller, BS; Karpatkin, S; Pearlstein, E, 1988) |
| "Indomethacin was able to reduce the levels of prostaglandin E (PGE) in the tumor tissue." | 1.26 | Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin. ( Fulton, AM; Levy, JG, 1980) |
| "Aspirin treatment, 150 mg/kg twice daily, inhibited growth of a transplantable mast-cell ascites tumor (P815) by 39-43% (p less than 0." | 1.26 | Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. ( Beaven, MA; Hial, V; Horakova, Z; Shaff, FE, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (50.00) | 18.7374 |
| 1990's | 4 (8.33) | 18.2507 |
| 2000's | 5 (10.42) | 29.6817 |
| 2010's | 14 (29.17) | 24.3611 |
| 2020's | 1 (2.08) | 2.80 |
| Authors | Studies |
|---|---|
| Youssif, BGM | 1 |
| Abdelrahman, MH | 1 |
| Abdelazeem, AH | 1 |
| Abdelgawad, MA | 1 |
| Ibrahim, HM | 1 |
| Salem, OIA | 1 |
| Mohamed, MFA | 1 |
| Treambleau, L | 1 |
| Bukhari, SNA | 1 |
| Lu, S | 1 |
| Obianom, ON | 1 |
| Ai, Y | 1 |
| Kumar, VL | 1 |
| Verma, S | 1 |
| Das, P | 1 |
| Zhang, Y | 1 |
| Wang, R | 1 |
| Li, W | 2 |
| Huang, G | 1 |
| Zhu, J | 1 |
| Cheng, J | 1 |
| He, D | 1 |
| Rahman, H | 1 |
| Kumar, D | 1 |
| Liu, T | 1 |
| Okwundu, N | 1 |
| Lum, D | 1 |
| Florell, SR | 1 |
| Burd, CE | 1 |
| Boucher, KM | 1 |
| VanBrocklin, MW | 1 |
| Grossman, D | 1 |
| Dong, Q | 1 |
| Wang, X | 1 |
| Hu, X | 1 |
| Xiao, L | 1 |
| Zhang, L | 1 |
| Song, L | 1 |
| Xu, M | 1 |
| Zou, Y | 1 |
| Chen, L | 1 |
| Chen, Z | 1 |
| Tan, W | 1 |
| Jyotsana, N | 1 |
| Zhang, Z | 1 |
| Himmel, LE | 1 |
| Yu, F | 1 |
| King, MR | 1 |
| Esquivias, P | 1 |
| Cebrián, C | 1 |
| Morandeira, A | 1 |
| Santander, S | 1 |
| Ortego, J | 1 |
| García-González, MA | 1 |
| Lanas, A | 1 |
| Piazuelo, E | 1 |
| Osman, NH | 1 |
| Said, UZ | 1 |
| El-Waseef, AM | 1 |
| Ahmed, ES | 1 |
| Balansky, R | 1 |
| Ganchev, G | 1 |
| Iltcheva, M | 1 |
| Micale, RT | 1 |
| La Maestra, S | 1 |
| D'Oria, C | 1 |
| Steele, VE | 1 |
| De Flora, S | 1 |
| Serebruany, VL | 1 |
| Cherepanov, V | 1 |
| Cabrera-Fuentes, HA | 1 |
| Kim, MH | 1 |
| Gao, M | 1 |
| Kong, Q | 1 |
| Hua, H | 1 |
| Yin, Y | 1 |
| Wang, J | 1 |
| Luo, T | 1 |
| Jiang, Y | 1 |
| Guo, Y | 1 |
| Liu, Y | 1 |
| Zhang, C | 1 |
| Su, ZY | 1 |
| Huang, MT | 1 |
| Kong, AN | 1 |
| Kashfi, K | 1 |
| Bousserouel, S | 1 |
| Gosse, F | 1 |
| Bouhadjar, M | 1 |
| Soler, L | 1 |
| Marescaux, J | 1 |
| Raul, F | 1 |
| Tang, CW | 1 |
| Tang, LP | 1 |
| Wang, CH | 1 |
| Bair, WB | 1 |
| Hart, N | 1 |
| Einspahr, J | 1 |
| Liu, G | 1 |
| Dong, Z | 1 |
| Alberts, D | 1 |
| Bowden, GT | 1 |
| BLANPIN, O | 1 |
| Miliaras, S | 1 |
| Miliaras, D | 1 |
| Vrettou, E | 1 |
| Zavitsanakis, A | 1 |
| Kiskinis, D | 1 |
| di Palma, A | 1 |
| Matarese, G | 1 |
| Leone, V | 1 |
| Di Matola, T | 1 |
| Acquaviva, F | 1 |
| Acquaviva, AM | 1 |
| Ricchi, P | 1 |
| Kunita, A | 1 |
| Kashima, TG | 1 |
| Morishita, Y | 1 |
| Fukayama, M | 1 |
| Kato, Y | 1 |
| Tsuruo, T | 1 |
| Fujita, N | 1 |
| Peterson, HI | 1 |
| Fulton, AM | 1 |
| Levy, JG | 1 |
| Chang, TH | 1 |
| Lee, YC | 1 |
| Lee, KY | 1 |
| Sun, CH | 1 |
| Chang, YP | 1 |
| Cohen, SM | 1 |
| Zenser, TV | 1 |
| Murasaki, G | 1 |
| Fukushima, S | 1 |
| Mattammal, MB | 1 |
| Rapp, NS | 1 |
| Davis, BB | 1 |
| Perkins, TM | 1 |
| Shklar, G | 1 |
| Hara, Y | 1 |
| Steiner, M | 1 |
| Baldini, MG | 1 |
| Tessitore, L | 1 |
| Costelli, P | 1 |
| Baccino, FM | 1 |
| Barnes, CJ | 1 |
| Lee, M | 1 |
| Hardman, WE | 1 |
| Cameron, IL | 1 |
| Rioux, N | 1 |
| Castonguay, A | 1 |
| Hilgard, P | 3 |
| Heller, H | 1 |
| Schmidt, CG | 1 |
| Glaves, D | 1 |
| Weiss, L | 1 |
| Droller, MJ | 1 |
| Perlmann, P | 1 |
| Schneider, MU | 1 |
| Grinwich, KD | 1 |
| Plescia, OJ | 1 |
| Thornes, RD | 1 |
| Pollard, M | 1 |
| Chang, CF | 1 |
| Luckert, PH | 1 |
| Cattan, A | 1 |
| Pourny, C | 1 |
| Carpentier, Y | 1 |
| Cattan, E | 1 |
| Barouh, M | 1 |
| Hial, V | 1 |
| Horakova, Z | 1 |
| Shaff, FE | 1 |
| Beaven, MA | 1 |
| Shparyk, IaV | 1 |
| Hart, DA | 1 |
| Karpatkin, S | 1 |
| Pearlstein, E | 1 |
| Ambrogio, C | 1 |
| Coller, BS | 1 |
| Kolenich, JJ | 1 |
| Mansour, EG | 1 |
| Flynn, A | 1 |
| Gasic, GJ | 1 |
| Gasic, TB | 1 |
| Murphy, S | 1 |
| Wood, S | 1 |
| Apps, MC | 1 |
| Cater, DB | 1 |
| Jaffe, BM | 1 |
| Frohberg, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Randomized Control Trial of the Effect of Sorafenib Combined With Aspirin in Preventing the Recurrence in High-risk Patients With Hepatocellular Carcinoma[NCT02748304] | 52 participants (Actual) | Interventional | 2016-04-30 | Terminated (stopped due to The enrollment of this study was slow. With the approval of lenvatinib in HCC,many patients choose the new drug, so subsequent enrollment may be more difficult.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for aspirin and Experimental Neoplasms
| Article | Year |
|---|---|
Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges.
Topics: Adenosine; Animals; Anticarcinogenic Agents; Aspirin; Blood Platelets; Carcinogenicity Tests; Clopid | 2015 |
Anticoagulants in the treatment of cancer.
Topics: Ancrod; Animals; Anticoagulants; Aspirin; Coumarins; Factor XIII; Fibrinolytic Agents; Heparin; Huma | 1976 |
[Indomethacin as a modulator of the activity of natural killer cells (a review of the literature)].
Topics: Adjuvants, Immunologic; Animals; Aspirin; Cells, Cultured; Drug Synergism; Humans; Indomethacin; Kil | 1990 |
Prostaglandins and cancer: an update.
Topics: Animals; Aspirin; Bucladesine; Calcium; Carcinoma; Cell Division; Cell Line; Depression, Chemical; H | 1974 |
[Present position of the toxicology of drugs].
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Amantadine; Aminopterin; Animals; Animals, Newbo | 1970 |
43 other studies available for aspirin and Experimental Neoplasms
| Article | Year |
|---|---|
Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Cell Survival; D | 2018 |
Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
Topics: Acrolein; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle Checkpoints; Cell Line, Tum | 2018 |
Artesunate suppresses inflammation and oxidative stress in a rat model of colorectal cancer.
Topics: 1,2-Dimethylhydrazine; Administration, Oral; Animals; Anti-Inflammatory Agents; Antineoplastic Agent | 2019 |
Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer.
Topics: A549 Cells; Animals; Antibiotics, Antineoplastic; Aspirin; Bismuth; Caffeine; Cell Proliferation; Ce | 2019 |
Aspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Models, Animal; DNA Damage; Kerat | 2021 |
Simultaneous Application of Photothermal Therapy and an Anti-inflammatory Prodrug using Pyrene-Aspirin-Loaded Gold Nanorod Graphitic Nanocapsules.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Combined Modality Therapy; Gold; Graphite; HeLa Cells; H | 2018 |
Minimal dosing of leukocyte targeting TRAIL decreases triple-negative breast cancer metastasis following tumor resection.
Topics: Animals; Apoptosis; Aspirin; Cell Line, Tumor; Cell Proliferation; Curcumin; Dioxolanes; E-Selectin; | 2019 |
Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model.
Topics: Adenocarcinoma; Animals; Aspirin; Barrett Esophagus; Dinoprostone; Disease Models, Animal; Esophagea | 2014 |
Luteolin supplementation adjacent to aspirin treatment reduced dimethylhydrazine-induced experimental colon carcinogenesis in rats.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Aspirin; Carcinoembryonic Ant | 2015 |
Selective inhibition by aspirin and naproxen of mainstream cigarette smoke-induced genotoxicity and lung tumors in female mice.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Cell Transformation, Neoplastic; Cyclooxygenase Inhibitor | 2016 |
AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Ag | 2016 |
The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.
Topics: Animals; Anticarcinogenic Agents; Aspirin; Azoxymethane; Colitis; Colonic Neoplasms; Cyclooxygenase | 2016 |
Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer Agents.
Topics: Animals; Antineoplastic Agents; Aspirin; Disulfides; Humans; MCF-7 Cells; Mice; Neoplasms, Experimen | 2015 |
Long-term administration of aspirin inhibits tumour formation and triggers anti-neoplastic molecular changes in a pre-clinical model of colon carcinogenesis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Azoxymethane; Carc | 2010 |
[Effects of combination of octreotide and aspirin on proliferation of human hepatocellular carcinoma].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Carcinoma, Hepatocellular; Cell Di | 2002 |
Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis.
Topics: Administration, Topical; Animals; Anticarcinogenic Agents; Aspirin; Biopsy, Needle; Cell Transformat | 2002 |
[KAOLIN- AND ACETYLSALICYLIC ACID-INDUCED EDEMA IN THE CANCEROUS RAT].
Topics: Aspirin; Drug Hypersensitivity; Edema; Kaolin; Neoplasms; Neoplasms, Experimental; Pharmacology; Rat | 1963 |
The effect of aspirin and high fibre diet on colorectal carcinoma: a comparative experimental study.
Topics: Animals; Aspirin; Chi-Square Distribution; Colorectal Neoplasms; Dietary Fiber; Dimethylhydrazines; | 2004 |
Aspirin reduces the outcome of anticancer therapy in Meth A-bearing mice through activation of AKT-glycogen synthase kinase signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Aspirin; Etopos | 2006 |
The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.
Topics: Animals; Aspirin; Blotting, Western; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Female; Flow | 2007 |
Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat.
Topics: Animals; Aspirin; Diclofenac; Fibrosarcoma; Indomethacin; Liver Neoplasms, Experimental; Neoplasm Tr | 1983 |
Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin.
Topics: Animals; Aspirin; Female; Humans; Immunosuppressive Agents; Indomethacin; Mice; Neoplasm Transplanta | 1980 |
Cocarcinogenic action of aspirin on gastric tumors induced by N-nitroso-N-methylnitroguanidine in rats.
Topics: Adenocarcinoma; Animals; Aspirin; Carcinoma, Squamous Cell; Cocarcinogenesis; Female; Humans; Male; | 1983 |
Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
Topics: Animals; Aspirin; Biotransformation; Cyclooxygenase Inhibitors; FANFT; Hyperplasia; Male; Neoplasms, | 1981 |
Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Aspirin; Carcinoma, Squamous Cell; | 1982 |
Characterization of the platelet-aggregating activity of tumor cells.
Topics: Adenocarcinoma; Adenosine Diphosphate; Animals; Aspirin; Cell Line; Cell Membrane; Growth Substances | 1980 |
Pharmacological interference with tissue hypercatabolism in tumour-bearing rats.
Topics: Adrenalectomy; Animals; Aspirin; Blood Glucose; Body Weight; Cachexia; Cathepsin D; Cholesterol; End | 1994 |
Aspirin suppresses 1,2-dimethylhydrazine-induced alteration of proliferative parameters in rat colonic crypts.
Topics: 1,2-Dimethylhydrazine; Animals; Aspirin; Cell Division; Dimethylhydrazines; Intestinal Mucosa; Male; | 1996 |
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents.
Topics: Animals; Anticarcinogenic Agents; Arachidonic Acid; Aspirin; Body Weight; Carcinogens; Drug Screenin | 1998 |
Anti-inflammatory drugs and tumour growth.
Topics: Animals; Aspirin; Bone Neoplasms; Carcinogens; Drug Evaluation; Humans; Indomethacin; Neoplasm Metas | 1979 |
The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL).
Topics: Animals; Aspirin; Bencyclane; Cyproheptadine; Dipyridamole; Female; Lung Neoplasms; Male; Mice; Mice | 1976 |
Initial tumor cell arrest in animals of defined coagulative status.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Carcinoma; Heparin; Lymphoma, Non-Hodgkin; Mice | 1978 |
Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells.
Topics: Antibody-Dependent Cell Cytotoxicity; Aspirin; Cell Line; Cytotoxicity, Immunologic; Dose-Response R | 1978 |
Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis.
Topics: Animals; Antibody Formation; Aspirin; Cell Line; Erythrocytes; Flufenamic Acid; Immunosuppression Th | 1977 |
Investigations on prostatic adenocarcinomas in rats.
Topics: Adenocarcinoma; Anesthetics; Animals; Aspirin; Cell Line; Female; Immunotherapy; Indomethacin; Lung | 1977 |
Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
Topics: Animals; Aspirin; Etoposide; Hemostasis; Heparin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm | 1977 |
Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse.
Topics: Animals; Aspirin; Body Weight; Cell Count; Histamine; Histidine Decarboxylase; Indomethacin; Mice; M | 1976 |
Indomethacin induces the suppression of plasma neutral proteinase activity in mice: possible relationship to efficacy as an anti-inflammatory drug and induction of alterations in the immune system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chlorides; Dose-Response Relationship, Dr | 1986 |
Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo.
Topics: Animals; Antibodies, Monoclonal; Aspirin; Blood Platelets; Humans; Immunologic Techniques; Lung Neop | 1988 |
Haematological effects of aspirin.
Topics: Adenocarcinoma; Animals; Aspirin; Heparin; Lung Neoplasms; Mice; Neoplasm Metastasis; Neoplasms, Exp | 1972 |
Anti-metastatic effect of aspirin.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Aspirin; Fibrosarcoma; Humans; Mice; Neoplasm Metast | 1972 |
Aspirin and tumour metastasis.
Topics: Animals; Aspirin; Blood Platelets; Lung Neoplasms; Neoplasm Metastasis; Neoplasms, Experimental; Rab | 1972 |
Production of histamine-like and prostaglandin-like substances from serum incubated with rat, dog, mouse or human tumours.
Topics: Acetates; Animals; Aspirin; Carcinoma, Hepatocellular; Complement System Proteins; Dogs; Histamine; | 1973 |